603 related articles for article (PubMed ID: 21388296)
41. Characteristics and outcomes of Klebsiella pneumoniae bacteraemia in Hong Kong.
Pau CK; Ma FF; Ip M; You JH
Infect Dis (Lond); 2015 May; 47(5):283-8. PubMed ID: 25697339
[TBL] [Abstract][Full Text] [Related]
42. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?
Damjanova I; Tóth A; Pászti J; Hajbel-Vékony G; Jakab M; Berta J; Milch H; Füzi M
J Antimicrob Chemother; 2008 Nov; 62(5):978-85. PubMed ID: 18667450
[TBL] [Abstract][Full Text] [Related]
43. [Characterization and molecular epidemiology of ESBL in Escherichia coli and Klebsiella pneumoniae in 11 Spanish hospitals (2004)].
Diestra K; Coque TM; Miró E; Oteo J; Nicolau CJ; Campos J; Moyá B; Curiao T; Pérez-Vázquez M; Cantón R; Oliver A; Navarro F;
Enferm Infecc Microbiol Clin; 2008; 26(7):404-10. PubMed ID: 18842234
[TBL] [Abstract][Full Text] [Related]
44. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
[TBL] [Abstract][Full Text] [Related]
45. Recurrent healthcare-associated community-onset infections due to Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.
Poulou A; Spanakis N; Pournaras S; Pitiriga V; Ranellou K; Markou F; Tsakris A
J Antimicrob Chemother; 2010 Dec; 65(12):2538-42. PubMed ID: 20876622
[TBL] [Abstract][Full Text] [Related]
46. Extended-spectrum beta-lactamase-producing Klebsiella spp. in a neonatal intensive care unit: risk factors for the infection and the dynamics of the molecular epidemiology.
Kristóf K; Szabó D; Marsh JW; Cser V; Janik L; Rozgonyi F; Nobilis A; Nagy K; Paterson DL
Eur J Clin Microbiol Infect Dis; 2007 Aug; 26(8):563-70. PubMed ID: 17587071
[TBL] [Abstract][Full Text] [Related]
47. Clinical significance of extended-spectrum beta-lactamases.
Rodríguez-Baño J; Pascual A
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):671-83. PubMed ID: 18847405
[TBL] [Abstract][Full Text] [Related]
48. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
Du B; Long Y; Liu H; Chen D; Liu D; Xu Y; Xie X
Intensive Care Med; 2002 Dec; 28(12):1718-23. PubMed ID: 12447513
[TBL] [Abstract][Full Text] [Related]
49. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.
Martinez P; Garzón D; Mattar S
Braz J Infect Dis; 2012; 16(5):420-5. PubMed ID: 22964287
[TBL] [Abstract][Full Text] [Related]
50. Pediatric extended spectrum β-lactamase infection: Community-acquired infection and treatment options.
Sethaphanich N; Santanirand P; Rattanasiri S; Techasaensiri C; Chaisavaneeyakorn S; Apiwattanakul N
Pediatr Int; 2016 May; 58(5):338-46. PubMed ID: 26513341
[TBL] [Abstract][Full Text] [Related]
51. Nosocomial liver abscess caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
Lin JC; Siu LK; Fung CP; Yeh KM; Chang FY
J Clin Microbiol; 2007 Jan; 45(1):266-9. PubMed ID: 17093025
[TBL] [Abstract][Full Text] [Related]
52. Predominance of an ST11 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae clone causing bacteraemia and urinary tract infections in Korea.
Ko KS; Lee JY; Baek JY; Suh JY; Lee MY; Choi JY; Yeom JS; Kim YS; Jung SI; Shin SY; Heo ST; Kwon KT; Son JS; Kim SW; Chang HH; Ki HK; Chung DR; Peck KR; Song JH
J Med Microbiol; 2010 Jul; 59(Pt 7):822-828. PubMed ID: 20360396
[TBL] [Abstract][Full Text] [Related]
53. Characteristics of Klebsiella pneumoniae bacteremia in community-acquired and nosocomial infections in diabetic patients.
Tsai SS; Huang JC; Chen ST; Sun JH; Wang CC; Lin SF; Hsu BR; Lin JD; Huang SY; Huang YY
Chang Gung Med J; 2010; 33(5):532-9. PubMed ID: 20979704
[TBL] [Abstract][Full Text] [Related]
54. Impact of extended spectrum beta-lactamase producing Klebsiella pneumoniae infections in severely burned patients.
Bennett JW; Robertson JL; Hospenthal DR; Wolf SE; Chung KK; Mende K; Murray CK
J Am Coll Surg; 2010 Sep; 211(3):391-9. PubMed ID: 20800197
[TBL] [Abstract][Full Text] [Related]
55. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
Zarakolu P; Metan G; Hasçelik G; Akova M
Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
[TBL] [Abstract][Full Text] [Related]
56. An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes.
Souli M; Galani I; Antoniadou A; Papadomichelakis E; Poulakou G; Panagea T; Vourli S; Zerva L; Armaganidis A; Kanellakopoulou K; Giamarellou H
Clin Infect Dis; 2010 Feb; 50(3):364-73. PubMed ID: 20041768
[TBL] [Abstract][Full Text] [Related]
57. Dissemination of multidrug-resistant blaCTX-M-15/IncFIIk plasmids in Klebsiella pneumoniae isolates from hospital- and community-acquired human infections in Tunisia.
Mansour W; Grami R; Ben Haj Khalifa A; Dahmen S; Châtre P; Haenni M; Aouni M; Madec JY
Diagn Microbiol Infect Dis; 2015 Nov; 83(3):298-304. PubMed ID: 26341707
[TBL] [Abstract][Full Text] [Related]
58. First Report of Extended-Spectrum Betalactamase-Producing
Aghamohammad S; Badmasti F; Solgi H; Aminzadeh Z; Khodabandelo Z; Shahcheraghi F
Microb Drug Resist; 2020 Mar; 26(3):261-269. PubMed ID: 30277830
[TBL] [Abstract][Full Text] [Related]
59. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
[TBL] [Abstract][Full Text] [Related]
60. Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome.
Kim YK; Pai H; Lee HJ; Park SE; Choi EH; Kim J; Kim JH; Kim EC
Antimicrob Agents Chemother; 2002 May; 46(5):1481-91. PubMed ID: 11959586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
